Beyond the Indication: Deprescribing for Safer Aging

Within 90 days, reduce non-concordant acid-suppression therapy by ≥15% from baseline among SNF residents receiving PPIs/H2RBs by aligning prescribing with guideline-supported indications and durations. Sought to reduce resident pill burden and medication-related harms, while modeling a scalable deprescribing process for the LTC environment